Jifeng Feng

Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial

Yi‐Long Wu, Shun Lü, Ying Cheng et al. · Journal of Thoracic Oncology · 2019 · 347 citations

Pyrotinib or Lapatinib Combined With Capecitabine in HER2–Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II Study

Fei Ma, Quchang Ouyang, Wěi Li et al. · Journal of Clinical Oncology · 2019 · 335 citations

MSX3 Switches Microglia Polarization and Protects from Inflammation-Induced Demyelination

Zhongwang Yu, Dingya Sun, Jifeng Feng et al. · Journal of Neuroscience · 2015 · 90 citations · Full text

Sintilimab versus docetaxel as second‐line treatment in advanced or metastatic squamous non‐small‐cell lung cancer: an open‐label, randomized controlled phase 3 trial (ORIENT‐3)

Yuankai Shi, Lin Wu, Xinmin Yu et al. · Cancer Communications · 2022 · 53 citations · Full text

Rosmarinic acid reduces the resistance of gastric carcinoma cells to 5-fluorouracil by downregulating FOXO4-targeting miR-6785-5p

Yu Chen, Dongqing Chen, Haixia Liu et al. · Biomedicine & Pharmacotherapy · 2018 · 51 citations · Full text